Transperineal TRUS-guided prostate brachytherapy using loose seeds versus RAPIDStrand: A dosimetric analysis

Brachytherapy

Volumn 3, Issue 3, 2004, Pages 136-140

  Fagundes, Humberto M ^a   Keys, Richard J ^a   Wojcik, Mary F ^a   Radden, Marsha A ^a   Bertelsman, Carol G ^a   Cavanagh, William A ^b  

^a MISSOURI BAPTIST MEDICAL CENTER   (United States)

^b Haakon Ragde Found Adv Cancer S   (United States)

Author keywords

Brachytherapy; D90; Dosimetry; Prostate cancer; V100

Indexed keywords

IODINE 125; LEAD;

ARTICLE; BRACHYTHERAPY; DOSIMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; TIME SERIES ANALYSIS; TRANSRECTAL ULTRASONOGRAPHY; TUMOR BIOPSY; URINE RETENTION;

BRACHYTHERAPY; HUMANS; MALE; PERINEUM; PROSTATIC NEOPLASMS; RADIATION MONITORING; RECTUM;

EID: 8144227333     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2004.05.006     Document Type: Article

References (32)

1. American Cancer Society Cancer facts and figures 2003 American Cancer Society Atlanta
2. C.L. Amling, M.L. Blute, and S.E. Lerner Influence of prostate-specific antigen testing on the spectrum of patients with prostate cancer undergoing radical prostatectomy at a large referral practice Mayo Clin Proc 73 1998 401 406
3. R.R. Bahnson, G.E. Hanks, and R.P. Huben NCCN Practice Guidelines for Prostate Cancer Oncology (Huntington) 14 11A 2000 111 119
4. J.C. Blasko, P.D. Grimm, and J.E. Sylvester Palladium-103 brachytherapy for prostate carcinoma Int J Radiat Oncol Biol Phys 46 2000 839 850
5. W.J. Catalona, and D.S. Smith Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: Intermediate-term results J Urol 160 6 1998 2428 2434
6. H. Ragde, G.L. Grado, and B.S. Nadir Brachytherapy for clinically localized prostate cancer: Thirteen-year disease-free survival of 769 consecutive prostate cancer patients treated with permanent implants alone Arch Esp Urol 54 2001 739 747
7. 125I brachytherapy Int J Radiat Oncol Biol Phys 51 2001 31 40
8. M. Han, A.W. Partin, and S. Piantadosi Era-specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer J Urol 166 2001 416 419
9. J. Sharkey, A. Cantor, and Z. Solc Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer Curr Urol Rep 3 2002 250 257
10. 125I implantation for stage T1/T2 prostatic carcinoma J Clin Oncol 14 1996 449 453
11. M.J. Zelefsky, S.A. Leibel, and P.B. Gaudin Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer Int J Radiat Oncol Biol Phys 41 1998 491 500
12. W.S. Bice Jr., B.R. Prestidge, and P.D. Grimm Centralized multi-institutional postimplant analysis for interstitial prostate brachytherapy Int J Radiat Oncol Biol Phys 41 1998 921 927
13. W.M. Butler, G.S. Merrick, and A.T. Dorsey Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy Int J Radiat Oncol Biol Phys 48 2000 1575 1582
14. C.M. Cha, L. Potters, and R. Ashley Isotope selection for patients undergoing prostate brachytherapy Int J Radiat Oncol Biol Phys 45 1999 391 395
15. 125I prostate implants Radiother Oncol 66 2003 173 179
16. W.R. Lee, A.F. deGuzman, and R.L. Bare Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: Evidence for a learning curve in the first year at a single institution Int J Radiat Oncol Biol Phys 46 2000 83 88
17. W.R. Lee, A.F. deGuzman, and S.K. Tomlinson Radioactive sources embedded in suture are associated with improved postimplant dosimetry in men treated with prostate brachytherapy Radiother Oncol 65 2002 123 127
18. G.S. Merrick, W.M. Butler, and J.H. Lief Temporal resolution of urinary morbidity following prostate brachytherapy Int J Radiat Oncol Biol Phys 47 2000 121 128
19. G.S. Merrick, W.M. Butler, and A.T. Dorsey Potential role of various dosimetric quality indicators in prostate brachytherapy Int J Radiat Oncol Biol Phys 44 1999 717 724
20. 103Pd postoperative dosimetric analysis Radiat Oncol Investig 5 1997 305 313
21. G.S. Merrick, W.M. Butler, and A.T. Dorsey Influence of timing on the dosimetric analysis of transperineal ultrasound-guided, prostatic conformal brachytherapy Radiat Oncol Investig 6 1998 182 190
22. R. Ove, K. Wallner, and K. Badiozamani Standardization of prostate brachytherapy treatment plans Int J Radiat Oncol Biol Phys 50 2001 257 263
23. 125I prostate implants Int J Radiat Oncol Biol Phys 41 1998 101 108
24. L. Potters, D. Huang, and P. Fearn The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy Brachytherapy 2 2003 26 31
25. J.J. Battermann I-125 implantation for localized prostate cancer: The Utrecht University experience Radiother Oncol 57 2000 269 272
26. G.L. Grado, T.R. Larson, and C.S. Balch Actuarial disease-free survival after prostate cancer brachytherapy using interactive techniques with biplane ultrasound and fluoroscopic guidance Int J Radiat Oncol Biol Phys 42 1998 289 298
27. 103Pd brachytherapy in 950 patients with prostate cancer Tech Urol 6 2000 128 134
28. 103Pd interstitial source calibration and dosimetry: Implications for dose specification and prescription Med Phys 27 2000 634 642
29. S. Nag, D. Beyer, and J. Friedland American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer Int J Radiat Oncol Biol Phys 44 1999 789 799
30. M.A. Fagundes, M. Leick, and C. Sabrito Permanent prostate gland seed implant: A dosimetry report of the Porto Alegre, Brazil experience comparing two different brachytherapy techniques Radiother Oncol 66 Suppl. 95 2003 S33
31. K. Wallner, G. Merrick, and L. True I-125 versus Pd-103 for low-risk prostate cancer: Morbidity outcomes from a prospective randomized multicenter trial Cancer J 8 2002 67 73
32. D.B. Fuller, and J.A. Koziol Prostate brachytherapy seed migration and dosimetry: Analysis of potential predictive factors Brachytherapy 2 2003 47